UNICA IRIS Institutional Research Information System

TRAMONTANO, ENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 412.907
NA - Nord America 16.226
AS - Asia 6.749
SA - Sud America 1.195
AF - Africa 198
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 14
Totale 437.312
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 408.832
US - Stati Uniti d'America 15.986
SG - Singapore 2.665
CN - Cina 2.591
SE - Svezia 1.101
BR - Brasile 967
UA - Ucraina 962
DE - Germania 583
VN - Vietnam 524
GB - Regno Unito 409
FI - Finlandia 366
FR - Francia 167
KR - Corea 162
HK - Hong Kong 147
IN - India 141
CA - Canada 138
AR - Argentina 100
NL - Olanda 89
MA - Marocco 77
MX - Messico 76
PL - Polonia 72
AT - Austria 71
JP - Giappone 70
TR - Turchia 68
BD - Bangladesh 51
ZA - Sudafrica 49
RU - Federazione Russa 46
IQ - Iraq 43
EC - Ecuador 40
ES - Italia 40
IR - Iran 37
ID - Indonesia 35
BE - Belgio 34
PK - Pakistan 32
IE - Irlanda 23
IL - Israele 21
UZ - Uzbekistan 21
VE - Venezuela 21
AU - Australia 19
CO - Colombia 19
CZ - Repubblica Ceca 17
AE - Emirati Arabi Uniti 15
AZ - Azerbaigian 14
PY - Paraguay 14
SA - Arabia Saudita 14
TW - Taiwan 14
KE - Kenya 13
DK - Danimarca 12
EG - Egitto 12
LT - Lituania 12
PT - Portogallo 12
TN - Tunisia 12
EU - Europa 11
NP - Nepal 11
PE - Perù 11
JO - Giordania 10
CH - Svizzera 9
KG - Kirghizistan 9
BO - Bolivia 8
DZ - Algeria 8
NO - Norvegia 8
CL - Cile 7
GE - Georgia 7
UY - Uruguay 7
GR - Grecia 6
HU - Ungheria 6
LV - Lettonia 6
OM - Oman 6
PA - Panama 6
NG - Nigeria 5
QA - Qatar 5
TH - Thailandia 5
AM - Armenia 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LB - Libano 4
MU - Mauritius 4
NZ - Nuova Zelanda 4
PH - Filippine 4
RO - Romania 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
HR - Croazia 3
JM - Giamaica 3
MY - Malesia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
A1 - Anonimo 2
BW - Botswana 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GT - Guatemala 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NI - Nicaragua 2
SN - Senegal 2
TJ - Tagikistan 2
AL - Albania 1
Totale 437.289
Salva come PNG Salva come JPEG
Città #
Cagliari 397.540
Uta 9.931
Ashburn 1.608
Fairfield 1.590
Woodbridge 1.319
Singapore 1.190
Chandler 993
Dallas 986
Houston 818
Boardman 765
Nyköping 726
Seattle 658
Wilmington 644
Ann Arbor 561
Cambridge 549
Beijing 540
Jacksonville 470
Dearborn 349
New York 322
Los Angeles 309
Santa Clara 243
Hefei 221
Shanghai 217
Boston 193
Nanjing 184
Helsinki 178
Dong Ket 170
Seoul 151
The Dalles 145
Buffalo 133
Ho Chi Minh City 131
Hong Kong 121
San Diego 105
Milan 104
Munich 90
Redwood City 88
Rome 88
São Paulo 87
Chicago 81
Herndon 71
Hanoi 67
Nanchang 67
Guangzhou 66
Redondo Beach 63
Casablanca 55
Changsha 55
London 55
Toronto 55
Warsaw 55
Tokyo 54
Mountain View 53
Phoenix 51
Shenyang 51
Tianjin 50
Atlanta 48
Hangzhou 45
Vienna 45
Sassari 42
Jiaxing 41
Amsterdam 40
Verona 40
Hebei 38
Nuremberg 38
Washington 37
Frankfurt am Main 36
Brooklyn 35
Rio de Janeiro 34
Redmond 33
Montreal 30
Lappeenranta 29
Mexico City 29
Stockholm 29
Wuhan 29
Norwalk 28
Jinan 26
Salt Lake City 26
San Francisco 25
Brussels 24
Council Bluffs 24
Denver 24
Curitiba 23
Poplar 23
Zhengzhou 23
Chennai 21
Dublin 21
Ottawa 21
Turku 21
Birmingham 20
Falls Church 20
Istanbul 20
Johannesburg 20
Manchester 20
Orem 20
Siracusa 20
Tashkent 20
Brasília 19
Columbus 19
Düsseldorf 19
Elk Grove Village 19
Guayaquil 19
Totale 426.749
Salva come PNG Salva come JPEG
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.756
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.693
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.632
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.485
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.402
Biological activities of aerial parts extracts of Euphorbia characias 4.395
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.293
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.148
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.711
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.486
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.436
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.413
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.406
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.397
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.380
Broad-range potential of Asphodelus microcarpus leaves extract for drug development 3.334
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.287
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.281
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.267
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.263
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.232
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.063
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.046
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.044
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.023
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.005
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 2.988
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 2.968
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 2.941
Purification and characterization of DR_2577 (SlpA) a major S-layer protein from Deinococcus radiodurans 2.940
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.892
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.882
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.870
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.864
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.850
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.841
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.835
On the S-layer of Thermus thermophilus and the assembling of its main protein SIpA 2.823
The S-layer protein DR_2577 binds deinoxanthin and under desiccation conditions protects against UV-radiation in Deinococcus radiodurans 2.822
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.820
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.794
Insights into Ebola VP35 oligomerization from molecular simulations 2.772
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.749
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.738
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity 2.730
null 2.719
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.701
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.684
ANALYSIS OF 98 HERV-K(HML-2) CONTAINING PROVIRUSES IDENTIFIED IN THE HUMAN GENOME ASSEMBLY GRCH37/HG19 BY RETROTECTOR AND THEIR GENOMIC CONTEXT 2.668
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.612
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.597
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.580
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.572
Identification of a novel HERV-K(HML10): comprehensive characterization and comparative analysis in non-human primates provide insights about HML10 proviruses structure and diffusion 2.538
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.529
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.507
Classification and characterization of human endogenous retroviruses; mosaic forms are common 2.484
Contribution of type W human endogenous retroviruses to the human genome: Characterization of HERV-W proviral insertions and processed pseudogenes 2.447
Human Endogenous Retrovirus type W distribution in the human genome: identification and characterization of a new set of proviral sequences in GRCh37/hg19 assembly 2.444
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.419
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.404
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships 2.396
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.394
Inhibition of HIV-1 reverse transcriptase associated activities by the hydroalcoholic extract of Casimiroa edulis seeds 2.389
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.368
Validation of a computed radiography device to monitor the HIV-1 RNase H activity 2.365
An efficient route to novel uracil-based drug-like molecules 2.342
null 2.329
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 2.317
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.313
Identification and genomic characterization of HERV-K (HML-10) in human genome GRCh37/hg19 assembly 2.293
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.282
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.230
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.230
HERV-W group evolutionary history in non-human primates: Characterization of ERV-W orthologs in Catarrhini and related ERV groups in Platyrrhini 2.219
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.210
Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments 2.200
Development and identification of a novel anti-HIV-1 peptide derived by modification of the N-terminal domain of HIV-1 integrase 2.194
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.125
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.101
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.100
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.086
Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses 2.078
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.066
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.063
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.046
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 2.040
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.039
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 2.038
New features of the cell wall of the radio-resistant bacterium Deinococcus radiodurans 2.033
6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach 2.010
Ebola virus VP35 blocks stress granule assembly 2.001
HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity 1.996
Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology 1.976
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.930
Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome 1.927
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.898
null 1.851
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.850
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.847
Totale 299.074
Salva come PNG Salva come JPEG
Categoria #
all - tutte 534.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 534.763
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139.261 0 0 0 0 0 9.705 6.662 5.980 2.364 5.624 6.403 2.523
2021/202223.462 2.379 1.875 1.195 1.419 1.852 1.786 1.324 1.202 2.274 2.345 2.865 2.946
2022/202340.300 3.440 5.633 4.589 3.519 2.514 4.377 1.973 3.178 2.117 2.391 3.242 3.327
2023/202438.637 2.373 1.373 2.010 3.476 3.722 6.385 5.038 3.012 1.887 2.286 3.411 3.664
2024/202591.439 15.305 41.501 10.614 7.743 3.619 4.266 5.061 362 795 596 716 861
2025/20269.483 1.402 681 2.392 1.934 1.762 1.312 0 0 0 0 0 0
Totale 438.275